Wedge Capital Management L L P Lantheus Holdings, Inc. Transaction History

Wedge Capital Management L L P

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2020 Jan 08, 2021	SELL	$10.75 - $14.91 $139,567 - $193,576	-12,983 Closed	0 $0
Q3 2020 Oct 08, 2020	BUY	$11.98 - $16.34 $155,536 - $212,142	12,983 New	12,983 $164,000
Q3 2018 Nov 01, 2018	SELL	$13.1 - $16.35 $1.35 Million - $1.69 Million	-103,101 Closed	0 $0
Q2 2018 Jul 31, 2018	BUY	$13.65 - $18.7 $215,137 - $294,730	15,761 Added 18.05%	103,101 $1.5 Million
Q1 2018 May 01, 2018	BUY	$14.85 - $24.3 $328,779 - $538,002	22,140 Added 33.96%	87,340 $1.39 Million
Q4 2017 Jan 31, 2018	SELL	$17.4 - $23.4 $252,299 - $339,300	-14,500 Reduced 18.19%	65,200 $1.33 Million
Q3 2017 Oct 31, 2017	BUY	$15.5 - $19.15 $1.24 Million - $1.53 Million	79,700	79,700 $1.42 Million

541

68.3M

679K

423K

Ticker LNTH
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 68,741,904
Market Cap $6.25B
Description
Lantheus Holdings, Inc. develops, manufactures, and commercializes diagnostic and therapeutic products that assist clinicians in the diagnosis and treatment of heart, cancer, and other diseases worldwide. It provides DEFINITY, a microbubble ultrasound enhancing agent used in ultrasound exams of the heart; TechneLite, a technetium generator for n...

Get notified when there are updates to the investment portfolio of Wedge Capital Management L L P, based on Form 13F filings with the SEC.

Stay updated on Wedge Capital Management L L P with notifications on news.